265 related articles for article (PubMed ID: 33600923)
1. Therapeutic effects of Wharton's jelly-derived Mesenchymal Stromal Cells on behaviors, EEG changes and NGF-1 in rat model of the Parkinson's disease.
Jalali MS; Saki G; Farbood Y; Azandeh SS; Mansouri E; Ghasemi Dehcheshmeh M; Sarkaki A
J Chem Neuroanat; 2021 Apr; 113():101921. PubMed ID: 33600923
[TBL] [Abstract][Full Text] [Related]
2. Transplanted Wharton's jelly mesenchymal stem cells improve memory and brain hippocampal electrophysiology in rat model of Parkinson's disease.
Jalali MS; Sarkaki A; Farbood Y; Azandeh SS; Mansouri E; Ghasemi Dehcheshmeh M; Saki G
J Chem Neuroanat; 2020 Dec; 110():101865. PubMed ID: 32991967
[TBL] [Abstract][Full Text] [Related]
3. Neuroprotective effects of Wharton's jelly-derived mesenchymal stem cells on motor deficits due to Parkinson's disease.
Jalali MS; Sarkaki A; Farbood Y; Azandeh SS; Mansouri E; Ghasemi Dehcheshmeh M; Saki G
Iran J Basic Med Sci; 2021 Sep; 24(9):1173-1181. PubMed ID: 35083003
[TBL] [Abstract][Full Text] [Related]
4. Globus pallidus, but not entopeduncular nucleus, 6-OHDA-induced lesion attenuates L-Dopa-induced dyskinesia in the rat model of Parkinson's disease.
Marin C; Bonastre M; Fuentes M; Mullol J
Pharmacol Biochem Behav; 2020 Oct; 197():173013. PubMed ID: 32758524
[TBL] [Abstract][Full Text] [Related]
5. Effects of bromelain on motor responses following intra-medial forebrain bundle 6-OHDA injection in rat model of parkinsonism.
Adu TS; Mabandla MV
Metab Brain Dis; 2019 Dec; 34(6):1557-1564. PubMed ID: 31332728
[TBL] [Abstract][Full Text] [Related]
6. Physical exercise and human adipose-derived mesenchymal stem cells ameliorate motor disturbances in a male rat model of Parkinson's disease.
Cucarián JD; Berrío JP; Rodrigues C; Zancan M; Wink MR; de Oliveira A
J Neurosci Res; 2019 Sep; 97(9):1095-1109. PubMed ID: 31119788
[TBL] [Abstract][Full Text] [Related]
7. Implication of nigral dopaminergic lesion and repeated L-dopa exposure in neuropsychiatric symptoms of Parkinson's disease.
Loiodice S; Wing Young H; Rion B; Méot B; Montagne P; Denibaud AS; Viel R; Drieu La Rochelle C
Behav Brain Res; 2019 Mar; 360():120-127. PubMed ID: 30521934
[TBL] [Abstract][Full Text] [Related]
8. PARKIN overexpression in human mesenchymal stromal cells from Wharton's jelly suppresses 6-hydroxydopamine-induced apoptosis: Potential therapeutic strategy in Parkinson's disease.
Bonilla-Porras AR; Arevalo-Arbelaez A; Alzate-Restrepo JF; Velez-Pardo C; Jimenez-Del-Rio M
Cytotherapy; 2018 Jan; 20(1):45-61. PubMed ID: 29079356
[TBL] [Abstract][Full Text] [Related]
9. Impact of the lesion procedure on the profiles of motor impairment and molecular responsiveness to L-DOPA in the 6-hydroxydopamine mouse model of Parkinson's disease.
Francardo V; Recchia A; Popovic N; Andersson D; Nissbrandt H; Cenci MA
Neurobiol Dis; 2011 Jun; 42(3):327-40. PubMed ID: 21310234
[TBL] [Abstract][Full Text] [Related]
10. Neuroprotective effects of garlic extract on dopaminergic neurons of substantia nigra in a rat model of Parkinson's disease: motor and non-motor outcomes.
Bigham M; Mohammadipour A; Hosseini M; Malvandi AM; Ebrahimzadeh-Bideskan A
Metab Brain Dis; 2021 Jun; 36(5):927-937. PubMed ID: 33656625
[TBL] [Abstract][Full Text] [Related]
11. Striatal inhibition of calpains prevents levodopa-induced neurochemical changes and abnormal involuntary movements in the hemiparkinsonian rat model.
Chagniel L; Robitaille C; Lebel M; Cyr M
Neurobiol Dis; 2012 Jan; 45(1):645-55. PubMed ID: 22037042
[TBL] [Abstract][Full Text] [Related]
12. Establishment of a 6-OHDA Induced Unilaterally Lesioned Male Wistar Rat Model of Parkinson's Disease.
Kumari N; Luthra PM
Methods Mol Biol; 2024; 2761():491-498. PubMed ID: 38427257
[TBL] [Abstract][Full Text] [Related]
13. Intracarotid Infusion of Mesenchymal Stem Cells in an Animal Model of Parkinson's Disease, Focusing on Cell Distribution and Neuroprotective and Behavioral Effects.
Cerri S; Greco R; Levandis G; Ghezzi C; Mangione AS; Fuzzati-Armentero MT; Bonizzi A; Avanzini MA; Maccario R; Blandini F
Stem Cells Transl Med; 2015 Sep; 4(9):1073-85. PubMed ID: 26198165
[TBL] [Abstract][Full Text] [Related]
14. Nerve growth factor increases survival of dopaminergic graft, rescue nigral dopaminergic neurons and restores functional deficits in rat model of Parkinson's disease.
Chaturvedi RK; Shukla S; Seth K; Agrawal AK
Neurosci Lett; 2006 May; 398(1-2):44-9. PubMed ID: 16423459
[TBL] [Abstract][Full Text] [Related]
15. An intermittent, controlled-rate, slow progressive degeneration model of Parkinson's disease: antiparkinson effects of Sinemet and protective effects of methylphenidate.
Fleming SM; Delville Y; Schallert T
Behav Brain Res; 2005 Jan; 156(2):201-13. PubMed ID: 15582106
[TBL] [Abstract][Full Text] [Related]
16. Conversion of human umbilical cord mesenchymal stem cells in Wharton's jelly to dopamine neurons mediated by the Lmx1a and neurturin in vitro: potential therapeutic application for Parkinson's disease in a rhesus monkey model.
Yan M; Sun M; Zhou Y; Wang W; He Z; Tang D; Lu S; Wang X; Li S; Wang W; Li H
PLoS One; 2013; 8(5):e64000. PubMed ID: 23724014
[TBL] [Abstract][Full Text] [Related]
17. Heat shock protein 60 affects behavioral improvement in a rat model of Parkinson's disease grafted with human umbilical cord mesenchymal stem cell-derived dopaminergic-like neurons.
Zhao C; Li H; Zhao XJ; Liu ZX; Zhou P; Liu Y; Feng MJ
Neurochem Res; 2016 Jun; 41(6):1238-49. PubMed ID: 26758268
[TBL] [Abstract][Full Text] [Related]
18. Neuroprotective Effects of Ellagic Acid in a Rat Model of Parkinson's Disease.
Sarkaki A; Farbood Y; Dolatshahi M; Mansouri SM; Khodadadi A
Acta Med Iran; 2016 Aug; 54(8):494-502. PubMed ID: 27701719
[TBL] [Abstract][Full Text] [Related]
19. Severity of Dyskinesia and D3R Signaling Changes Induced by L-DOPA Treatment of Hemiparkinsonian Rats Are Features Inherent to the Treated Subjects.
Albarrán-Bravo S; Ávalos-Fuentes JA; Cortés H; Rodriguez-Sánchez M; Leyva-García N; Rangel-Barajas C; Erlij D; Florán B
Biomolecules; 2019 Sep; 9(9):. PubMed ID: 31480516
[TBL] [Abstract][Full Text] [Related]
20. 1,25-Dihydroxyvitamin D3 administration to 6-hydroxydopamine-lesioned rats increases glial cell line-derived neurotrophic factor and partially restores tyrosine hydroxylase expression in substantia nigra and striatum.
Sanchez B; Relova JL; Gallego R; Ben-Batalla I; Perez-Fernandez R
J Neurosci Res; 2009 Feb; 87(3):723-32. PubMed ID: 18816795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]